an accelerated timeline that could lead to a coronavirus vaccine that's ready for emergency use in early 2021.
"We are moving on an accelerated timeline toward Phase 1 human clinical trials at the latest by September 2020 and, supported by the global production capability that we are scaling up in parallel to this testing, we expect a vaccine could be ready for emergency use in early 2021," said Paul Stoffels, J&J's chief scientific officer, in a statement.There are more than 40 potential coronavirus vaccines in the works.
J&J has been researching the genetic sequence of the coronavirus since January in partnership with Beth Israel Deaconess Medical Center. After producing several vaccines, they were tested to identify the most promising ones at causing an immune response. The update shortens an already quick timeline for vaccine development, Previously, J&J said it was aiming to start testing a coronavirus vaccine in humans in November.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »